Quark Venture
A Vancouver-based VC firm focused on the biotech and life sciences space
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Quark Venture Information
Geographic Data
Address: No 2500-1075 West Georgia Street
City: Vancouver
State: british columbia
Zip: V6E 2M6
Country: CA
Financial Info
Stage:
Raised Last:
$0
Raised Total:$25M
Social
Linkedin
Crunchbase
Metrics
3,751,304Website Global Rank
3,440Website Monthly Traffic
Twitter Followers
Description
Established in 2015, Quark Venture Inc. is a venture capital investment firm, headquartered in Vancouver, Canada, and is focused on equity financing of innovative biotechnology and health sciences companies with breakthrough technology platforms and projects.
Contact Phone:
+17782388766
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2020 | Eyevensys | Series B | 30M |
| 6/2021 | Lyndra Therapeutics | Series C | 0 |
| 2/2019 | Lyndra Therapeutics | Series B | 0 |
| 4/2018 | V-Wave | Series C | 0 |
| 12/2022 | Alpha9 Theranostics | Series B | 0 |
| 2/2020 | Volastra Therapeutics | Seed | 12M |
| 12/2017 | ARTMS | Venture Round | 3M |
| 7/2017 | Physiq | Series B | 8M |
| 1/2017 | Microbion | Venture Round | 25M |
| 12/2019 | Raziel Therapeutics | Series C | 0 |
| 8/2017 | Sitka Biopharma | Seed Round | 2.4M |
| 12/2016 | SQZ Biotech | Series B | 8.3M |
| 9/2020 | V-Wave | Series C | 0 |
| 5/2018 | Canary Medical | Funding Round | - |
| 5/2018 | Canary Medical | Venture Round | - |
| 10/2016 | MSI Methylation Sciences | Venture Round | 30M |
| 6/2017 | Eloxx | Series C | 30M |
| 5/2019 | Pi Therapeutics | Series B | 19.7M |
| 1/2019 | Keros Therapeutics | Series B | 0 |
| 12/2019 | Raziel Health | Series C | 0 |
| 10/2017 | CathWorks | Series B | 0 |
| 6/2017 | PHEMI | Series B | 0 |
| 4/2021 | Volastra Therapeutics | Seed | 32M |
| 10/2018 | Sitka Biopharma | Venture Round | 1.9M |
| 5/2018 | Canary Medical | Venture Round | 0 |
| 1/2017 | Biscayne Pharmaceuticals | Series B | 3M |
| 4/2016 | Sitka Biopharma | Seed Round | - |
| 2/2020 | EnClear Therapies | Series A | 0 |
| 1/2017 | Biscayne NeuroTherapeutics | Series B | 3M |
| 3/2021 | CalciMedica | Series D | 0 |
| 4/2017 | Lyndra Therapeutics | Series A | 0 |
| 10/2017 | Bioarray Therapeutics | Series B | 4M |
| 8/2017 | Eloxx | Series C | 0 |
| 6/2021 | Lyndra Therapeutics | Series C | 0 |
| 4/2021 | Volastra Therapeutics | Seed Round | 0 |
| 3/2021 | CalciMedica | Series D | 0 |
| 9/2020 | V-Wave | Series C | 0 |
| 2/2020 | EnClear Therapies | Series A | 0 |
| 2/2020 | Volastra Therapeutics | Seed Round | 0 |
| 1/2020 | Eyevensys | Series B | 0 |
| 12/2019 | Raziel Health | Series C | 0 |
| 12/2019 | Raziel Therapeutics | Series C | 0 |
| 5/2019 | Pi Therapeutics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
